Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 27, 2026
Rollins (ROL) Drops -17% Over 30 Days After Earnings Miss and Piper Sandler Downgrade

Rollins (ROL) Drops -17% Over 30 Days After Earnings Miss and Piper Sandler Downgrade

Key Takeaways

  • Rollins shares fell approximately 17% over the last 30 days, closing near $30.03 after trading around $36.38 a month earlier.
  • The slide was driven by a Q2 2026 earnings miss and a Piper Sandler downgrade that cut the price target from $46 to $33.
  • Analysts flagged agentic AI search disruption and rising private-equity competition as risks to Rollins' organic growth goals.
  • Over the trailing quarter, the stock is down roughly 24%, extending a year-to-date decline of about 45% to 48%.
  • Rollins remains a leading global pest-control provider with recurring revenue, strong margins, and a growing dividend.

Rollins (ROL) Company Overview and Market Position

Rollins, Inc. is a premier global consumer and commercial services company best known for its pest-control operations. Through brands including Orkin, HomeTeam Pest Defense, Clark Pest Control, Fox, and Western Pest Services, the company provides termite, rodent, and insect protection to more than 2.8 million residential and commercial customers across North America, South America, Europe, Asia, Africa, and Australia, with roughly 22,000 employees operating from more than 850 locations.

Rollins is one of the largest players in a fragmented, route-based pest-control industry, holding an estimated 20% to 25% of the North American market and competing closely with UK-based Rentokil Initial (RTO). Its business is anchored by recurring service contracts that generate predictable revenue and cash flow, and it has paired organic growth with a steady cadence of bolt-on acquisitions. Investors have long followed the stock for its recession-resistant demand, high margins, and extended record of dividend increases. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Rollins (ROL) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, ROL shares declined about 17%, falling from a closing price near $36.38 to roughly $30.03. The move was not linear: the stock drifted lower through early-to-mid September before accelerating in the final week of the period, when analyst revisions and a single-session drop of more than 6% pushed shares toward fresh 52-week lows.

The last quarter has compounded that weakness. Over the trailing three months, the stock is down roughly 24%, reflecting a broader de-rating that has persisted for much of 2026. On a year-to-date basis, shares have fallen approximately 45% to 48%, and the stock trades more than 50% below its 52-week high of $66.14 reached in February 2026.

What Drove ROL Stock Price in the Last 30 Days

The most direct catalyst was a downgrade from Piper Sandler, which cut Rollins to Neutral from Overweight and lowered its price target to $33 from $46. The analyst cited concern that "agentic" AI search tools may increasingly direct prospective customers toward smaller, local pest-control operators rather than national brands, while an influx of private-equity capital has intensified competition across the industry. The firm also said it no longer sees a clear path for Rollins to return to its 7% to 8% organic-growth target. Shares fell more than 6% in the following session.

The downgrade landed on ground already softened by disappointing second-quarter results. Rollins reported adjusted earnings per share of $0.32, below the roughly $0.34 consensus estimate, and revenue of about $1.08 billion, slightly under analyst projections. Revenue still grew 7.9% year over year, but organic growth slowed to 5.7%, and gross margin contracted 100 basis points to 52.8% amid higher personnel, healthcare, and fuel costs. JPMorgan also trimmed its price target to $40 from $45 while maintaining a Neutral rating.

What Drove ROL Stock Performance Over the Last Quarter

The quarterly decline reflects a longer-running reassessment of Rollins' premium valuation. Through 2026, the stock has de-rated from historically elevated multiples as investors digested softer residential demand, margin compression tied to customer-acquisition and wage inflation, and a management transition. At its investor day and in subsequent conference appearances, leadership acknowledged double-digit declines in certain lead-generation channels, while noting that recurring services, termite, and ancillary business remained healthier than one-time treatments.

The competitive backdrop has also shifted. The same AI-search concerns highlighted by Piper Sandler, combined with increased private-equity activity in the sector, have raised questions about whether Rollins' scale and brand advantage will translate into sustained organic growth at prior rates. Despite these pressures, the company continues to generate strong free cash flow, maintains leverage of about 1x, and has kept raising its dividend. From what I see, this resilience in cash flow remains a key factor to monitor.

ROL Stock Forecast Drivers: What Investors Should Watch Next

Investors will be watching whether organic growth stabilizes as management guides toward at least 6% for the full year. Upcoming earnings reports will be critical for confirming whether lead-generation softness, particularly in digital channels, persists or reverses with seasonal pest pressure. Any commentary on how AI-driven search is affecting customer acquisition, as well as updates on private-equity competition and the pace of bolt-on acquisitions, will likely shape sentiment.

Margin trajectory also matters, given management's stated goals for incremental margin improvement and ongoing cost initiatives around fleet, procurement, and healthcare. Broader macroeconomic factors, including consumer spending and fuel costs, remain relevant to both demand and profitability. While consensus analyst targets still sit well above the current share price, the near-term path will hinge on evidence that organic momentum and margins are recovering. I’m watching this closely as the next few quarters unfold.

Exploring AI Tools in My Analysis Workflow

In my day-to-day research, I frequently review Tickeron's Trending AI Robots page. It highlights a curated selection of AI-powered trading bots drawn from a broader universe of hundreds of bots trading thousands of tickers. Because only the top-performing and most relevant bots appear in this section, it offers a focused way to explore automated strategies that span different approaches, timeframes, and performance metrics. Each bot operates with its own methodology, so reviewing their individual characteristics can help traders identify approaches that align with their own objectives and risk tolerance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ROL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ROL in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 24, 2026

ROL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 38 cases where ROL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 66%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where ROL advanced for three days, in 187 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ROL as a result. In 42 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.

The Moving Average Convergence Divergence Histogram (MACD) for ROL turned negative on September 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 27 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 59%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ROL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

The Aroon Indicator for ROL entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.111) is normal, around the industry mean (7.742). P/E Ratio (27.352) is within average values for comparable stocks, (51.486). Projected Growth (PEG Ratio) (2.413) is also within normal values, averaging (4.440). Dividend Yield (0.024) settles around the average of (0.019) among similar stocks. ROL's P/S Ratio (4.124) is slightly higher than the industry average of (1.645).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. ROL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ROL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Industry description

Personnel Services comprise companies that provide staffing and human resources management solutions for businesses. Each company might be involved in one or more types of recruitment or employee solutions such as permanent or temporary staffing, career consulting, outsourcing, administrative services and many more. Some personnel services companies cater to large businesses, while some specialize in providing services to small/medium-sized organizations. These specialized services potentially expedite the process of getting the ‘right’ candidates and/or training them to meet the requirements of a business process. Some of the companies also cover other critical areas like internal auditing for a company. Robert Half International Inc., ManpowerGroup Inc. and Insperity, Inc. are examples of companies in the personnel services industry.

Market Cap

The average market capitalization across the Personnel Services Industry is 3.1B. The market cap for tickers in the group ranges from 1.25K to 14.45B. ROL holds the highest valuation in this group at 14.45B. The lowest valued company is GXXM at 1.25K.

High and low price notable news

The average weekly price growth across all stocks in the Personnel Services Industry was -3%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was -4%. RGS experienced the highest price growth at 6%, while TRNR experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Personnel Services Industry was -49%. For the same stocks of the Industry, the average monthly volume growth was 45% and the average quarterly volume growth was 74%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 67
Price Growth Rating: 65
SMR Rating: 60
Profit Risk Rating: 88
Seasonality Score: -36 (-100 ... +100)
View a ticker or compare two or three
ROL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of pest & termite control services

Industry PersonnelServices

Industry
Other Consumer Services
Address
2170 Piedmont Road, N.E.
Phone
+1 404 888-2000
Employees
21946
Web
https://www.rollins.com
Interact to see
Advertisement
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.
Rollins (ROL) Drops -17% Over 30 Days After Earnings Miss and Piper Sandler Downgrade